Chargement en cours...
A Rare Case of Ticagrelor-Induced Profound Isolated Thrombocytopenia
Ticagrelor is a new oral antiplatelet drug that has a strong proven benefit of reducing the rate of death from cardiovascular causes, myocardial infarction, and stroke compared with clopidogrel. Ticagrelor is widely used by patients with acute coronary syndrome. However, profound thrombocytopenia ha...
Enregistré dans:
| Publié dans: | Acta Cardiol Sin |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taiwan Society of Cardiology
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5611356/ https://ncbi.nlm.nih.gov/pubmed/28959112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS20161021C |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|